688658.SH
悦康药业
SSE · Healthcare · Biotechnology · CN
CNY 13.21
−7.69%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 33.85x
- P/E 2027E
- 15.56x
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- -22.66x
- PEG TTM
- —
- Price / book
- 1.85x
- Price / sales
- 2.51x
- Price / cash flow
- 20.06x
Enterprise value
- Enterprise value
- CNY 5.8B
- EV / sales
- 2.40x
- EV / EBITDA
- -203.36x
- EV / EBIT
- -28.21x
- Market cap
- CNY 5.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026